Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

28. April 2026 13:49 ET | Quelle: FDA

FDA Announces Major Steps to Implement Real-Time Clinical Trials

White Oak, Md., April 28, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced two major steps as part of an initiative to advance the implementation of real-time clinical...
28. April 2026 09:29 ET | Quelle: Research and Markets

Biosimulation Market Report 2025 with Analyst Insights - Advancements in Precision Oncology and Integration with Digital Twins - Global Forecast to 2030

Dublin, April 28, 2026 (GLOBE NEWSWIRE) -- The "Biosimulation Market (2025 Edition)" report has been added to ResearchAndMarkets.com's offering. The growth of this Market is expected to be...
27. April 2026 11:59 ET | Quelle: AGC Biologics, Inc.

AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance

AGC Biologics is the 2026 Fierce Outsourcing Award recipient for Leadership in Regulatory and Quality Compliance.
23. April 2026 10:12 ET | Quelle: Leinco Technologies, Inc.

Leinco Technologies and CellCarta Collaborate to Advance Proteomics Solutions and Applications for Drug Development

St. Louis, MO, April 23, 2026 (GLOBE NEWSWIRE) -- Leinco Technologies, a leader in antibody and protein development, and CellCarta, a global provider of precision medicine laboratory services, are...
22. April 2026 08:00 ET | Quelle: Paratus Sciences Corporation

Paratus Appoints Alicia Secor as President and Chief Executive Officer; Expands Leadership Team to Support Next Phase of Growth

Bolstered leadership team positions Paratus to accelerate PS-1001 toward the clinic and build a pipeline of differentiated medicines.
17. April 2026 08:00 ET | Quelle: Lexicon Pharmaceuticals, Inc.

Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting

Oral presentation highlights additional data from PROGRESS Phase 2b study of pilavapadin supporting selection of 10mg as optimal dose for Phase 3 development in DPNP New data on spasticity further...
16. April 2026 10:34 ET | Quelle: Research and Markets

Measuring Performance in Clinical Research Management Course: How to Use Metrics Effectively to Gain Real, Actionable Insights Into the Progress of Your Clinical Research Projects (ONLINE)

Dublin, April 16, 2026 (GLOBE NEWSWIRE) -- The "Measuring Performance in Clinical Research Management (May 6, 2026)" training has been added to ResearchAndMarkets.com's offering. This...
14. April 2026 10:59 ET | Quelle: Research and Markets

Drug Development Services Market Research Report 2026: $50+ Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Drug Development Services Market Report 2026" has been added to ResearchAndMarkets.com's offering. The drug development services market has...
14. April 2026 03:26 ET | Quelle: Mordor Intelligence

Cell Line Development Market to Reach $8.95 Bn by 2031 with Gene & Cell Therapy Manufacturing Growing at 10.88% CAGR, Says Mordor Intelligence

Cell line development market driven by biologics, mAbs and gene therapies, with innovation and automation led by Thermo Fisher, Merck, Danaher, Lonza.
02. April 2026 08:07 ET | Quelle: Curanex Pharmaceuticals Inc

Curanex Expands Its Drug Development Pipeline to Include Cancer Cachexia, Representing a Multi-Billion-Dollar Market Opportunity and Important Step In The Company’s Evolution Into a Broader Therapeutics Development Company

Company expands strategic focus into one of oncology’s most urgent supportive-care challenges Jericho, New York, April 02, 2026 (GLOBE NEWSWIRE) -- Curanex Pharmaceuticals, Inc. (Nasdaq: CURX)...

Nächste Seite